Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NYX-2925 in Fibromyalgia
NCT03249103Phase 2Completed
- Sponsor
- Aptinyx Inc.
- Start
- Aug 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NYX-2925 in fibromyalgia (FM), sponsored by Aptinyx Inc.. Started Aug 2017; status: completed.
02
Drugs
NYX-2925
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT03249103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249103.